Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Director Directorships Declaration

19 Nov 2008 16:30

RNS Number : 5199I
Vernalis PLC
19 November 2008
Β 

ο»Ώ

19Β November 2008

VernalisΒ plc (LSE: VER)

As required under Listing Rule 9.6.13, VernalisΒ plc announces that Ian Garland wasΒ previouslyΒ a directorΒ of Acambis Plc. In addition, as required under Listing Rule 9.6.13(3), David MackneyΒ isΒ a director ofΒ Akubio Limited, which went intoΒ administrationΒ inΒ 2007.

-- ends --

Enquiries:

Vernalis plc

+44 (0) 118 977 3133

Peter Fellner, Executive Chairman

Β 

Β 

Brunswick Group

+44 (0) 20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDNBUBDBRUBGGIC
Date   Source Headline
5th Oct 20094:40 pmRNSSecond Price Monitoring Extn
5th Oct 20094:35 pmRNSPrice Monitoring Extension
22nd Sep 20094:35 pmRNSPrice Monitoring Extension
18th Sep 20094:40 pmRNSSecond Price Monitoring Extn
18th Sep 20094:35 pmRNSPrice Monitoring Extension
15th Sep 20097:00 amRNSRecruitment Completed in V3381 Phase II Study
9th Sep 20092:29 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
24th Aug 20094:18 pmRNSHolding(s) in Company
21st Aug 20095:22 pmRNSHolding(s) in Company
20th Aug 20094:48 pmRNSAdmission of Subscription Shares to GSK
12th Aug 200911:59 amRNSHolding(s) in Company
11th Aug 20094:21 pmRNSHolding(s) in Company
11th Aug 20094:19 pmRNSHolding(s) in Company
6th Aug 20097:00 amRNSAnnouncement of Interim Results
6th Aug 20097:00 amRNSVernalis and GlaxoSmithKline enter collaboration
6th Aug 20097:00 amRNSInterest in shares in Vernalis plc
21st Jul 20097:00 amRNSNew Oncology Development Candidate Announced
16th Jul 20097:00 amRNSVernalis receives milestone payment from Novartis
8th Jul 200911:00 amRNSNotice of 2009 Half Year Results
25th Jun 20091:00 pmRNSResult of AGM
3rd Jun 20097:00 amRNSInterim Management Statement
2nd Jun 20094:54 pmRNSHolding(s) in Company
2nd Jun 20092:36 pmRNSApproval for Frovatriptan in Korea secured
1st Jun 20094:43 pmRNSDirector/PDMR Shareholding
29th May 20094:39 pmRNSDirector/PDMR Shareholding
28th May 20096:27 pmRNSAnnual Information Update
21st May 20094:09 pmRNSDirector/PDMR Shareholding-Amendment
21st May 20094:02 pmRNSHolding(s) in Company
21st May 20093:58 pmRNSAGM + Annual Report Notice
20th May 20094:11 pmRNSDirector/PDMR Shareholding
20th May 20093:14 pmRNSHolding(s) in Company
18th May 20091:00 pmRNSResult of General Meeting
18th May 20097:00 amRNSResults of Placing & Open Offer
13th May 20095:11 pmRNSDirector/PDMR Shareholding
7th May 20097:00 amRNSNew three-year Collaboration with Servier
30th Apr 20097:00 amRNSPublication of Prospectus
29th Apr 20094:00 pmRNSAnnual Financial Report
29th Apr 20097:00 amRNSPlacing and Open Offer
29th Apr 20097:00 amRNSFinal Results
27th Mar 20097:00 amRNSPipeline update
29th Dec 200810:00 amRNSDirector/PDMR Shareholding
24th Dec 200812:00 pmRNSHolding(s) in Company
22nd Dec 20084:27 pmRNSHolding(s) in Company
15th Dec 20084:35 pmRNSPrice Monitoring Extension
19th Nov 20084:30 pmRNSDirector Directorships Declaration
14th Nov 20087:00 amRNSAppointment of new CEO and new CFO
14th Nov 20087:00 amRNSInterim Management Statement
13th Nov 20084:42 pmRNSSecond Price Monitoring Extn
13th Nov 20084:37 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.